Literature DB >> 12970008

Inpatient chronic assisted ventilatory care: a 15-year experience.

Peter J Wijkstra1, Monica A Avendaño, Roger S Goldstein.   

Abstract

STUDY
OBJECTIVES: Ventilator users who are unable to leave the acute care setting may be transferred to a unit for chronic assisted ventilatory care (CAVC) with the goal of optimizing their level of function. In this report, we summarize the outcomes of all patients admitted to a CAVC unit between 1986 and 2001. PATIENTS AND METHODS: Fifty patients (24 with neuromuscular disease [NMD], 10 with spinal cord injury [SCI], 7 with thoracic restriction [TR], 7 with COPD, and 2 with parenchymal restriction [PR]) were reviewed. Thirty-eight patients were transferred to the CAVC unit from intensive care, 5 patients were transferred from inpatient respiratory rehabilitation, 4 patients came from home, and 3 patients came from pediatric long-term care. At the time of CAVC unit admission, all patients were receiving mechanical ventilation via a tracheostomy tube.
RESULTS: Ventilator time increased gradually in patients with COPD from 16 h (SD, 5.6) to 22.9 h (SD, 3.0) per day (p < 0.05), and in patients with TR from 18.9 h (SD, 6.1) to 22.9 h (SD, 4.5) [not significant]. Five of the 10 patients with SCI were decannulated. Functional mobility, which decreased in patients with COPD and patients with TR, remained stable in NMD and PR and improved in SCI. Eighteen patients returned home or to an attendant care facility (COPD, n = 1; NMD, n = 10; SCI, n = 5; PR, n = 2); 11 patients died in the CAVC unit (COPD, n = 6; TR, n = 3; NMD, n = 1; SCI, n = 1); and 7 patients were transferred to intensive care, where they died. The average direct cost per patient per diem increased from $252 (Canadian) in 1988 to $335 in 2001.
CONCLUSION: A CAVC unit can provide a safe environment for severely impaired, ventilator-dependent individuals, many of whom (36%) left for a more independent community-based environment. Better outcomes were seen among patients with SCI and NMD than in patients with COPD and TR.

Entities:  

Mesh:

Year:  2003        PMID: 12970008     DOI: 10.1378/chest.124.3.850

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Sleep, sleep disordered breathing, and nocturnal hypoventilation in children with neuromuscular diseases.

Authors:  Raanan Arens; Hiren Muzumdar
Journal:  Paediatr Respir Rev       Date:  2010-03       Impact factor: 2.726

2.  Characteristics and outcome of patients with difficult weaning from mechanical ventilation: an 18 years' experience of a respiratory intermediate unit attached to a pulmonary department.

Authors:  V Tsara; N Moisiadis; M Antoniadou; E Serasli
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

3.  Institutional care for long-term mechanical ventilation in Canada: A national survey.

Authors:  Louise Rose; Douglas McKim; Sherri Katz; David Leasa; Mika Nonoyama; Cheryl Pedersen; Monica Avendano; Roger Goldstein
Journal:  Can Respir J       Date:  2014-09-03       Impact factor: 2.409

4.  Successful decannulation of patients with traumatic spinal cord injury: A scoping review.

Authors:  Gordon H Sun; Stephanie W Chen; Mark P MacEachern; Jing Wang
Journal:  J Spinal Cord Med       Date:  2020-11-09       Impact factor: 2.040

5.  Severe Protracted Hypophosphatemia in a Patient with Persistent Vegetative State on Long-Term Assisted Respiratory Support.

Authors:  Yulia Namestnic; Hamza Shwieke; Samuel N Heyman; Esther-Lee Marcus
Journal:  Am J Case Rep       Date:  2022-02-26

6.  Registered respiratory therapists as force multipliers in interprofessional complex continuing care.

Authors:  Wrae Hill; Cory Bendall
Journal:  Can J Respir Ther       Date:  2015

Review 7.  Mortality outcomes of patients on chronic mechanical ventilation in different care settings: A systematic review.

Authors:  Stephanie M Sison; Gayathri K Sivakumar; Christine Caufield-Noll; William B Greenough; Esther S Oh; Panagis Galiatsatos
Journal:  Heliyon       Date:  2021-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.